Bioceltix S.A. (BCX.WA)
PLN 79.8
(4.04%)
PLN 79.8
(4.04%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -14.77 Million | -7.9 Million | -4.04 Million | -1.51 Million | -1.66 Million | -1.78 Million |
| Net Income | -13.68 Million | -8.92 Million | -4.39 Million | -2.34 Million | -1.59 Million | -775.69 Thousand |
| Depreciation & Amortization | 434.79 Thousand | 445.38 Thousand | 376.97 Thousand | 222.91 Thousand | 48.38 Thousand | 13.96 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -1.52 Million | 624.43 Thousand | 45.29 Thousand | 636.76 Thousand | -141.94 Thousand | -1.02 Million |
| Other non-cash items | 1.92 Million | -192.67 Thousand | 911.32 Thousand | -89.19 Thousand | -296.44 Thousand | 1.05 Million |
| Investing Cash Flow | -458.35 Thousand | -351.73 Thousand | 134.05 Thousand | -13.9 Thousand | -179.66 Thousand | -523.19 Thousand |
| Investments in PPE | -458.35 Thousand | -351.73 Thousand | -5984.09 | -13.9 Thousand | -179.66 Thousand | -523.19 Thousand |
| Acquisitions | - | - | 140.04 Thousand | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -458.35 Thousand | - | - | - | - | - |
| Financing Cash Flow | 20.42 Million | 6.32 Million | 6.75 Million | 3.62 Million | 1.37 Million | 1.49 Million |
| Debt repayment | -118.88 Thousand | - | - | -300 Thousand | -1.37 Million | -1.49 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 20.66 Million | 6.52 Million | 7.17 Million | 4.12 Million | - | - |
| Other Financing Activities | -122.24 Thousand | - | - | - | -1842.93 | - |
| Accounts receivables | -1.5 Million | 215.35 Thousand | -253.34 Thousand | 263.69 Thousand | 440.69 Thousand | -1.18 Million |
| Accounts payables | 464.42 Thousand | 813.45 Thousand | 18.97 Thousand | 254.79 Thousand | -21.74 Thousand | 156.75 Thousand |
| Inventory | -8617.89 | - | 11.84 Thousand | -6364.14 | -5477.61 | - |
| Other working capital | -474.63 Thousand | -404.37 Thousand | 267.82 Thousand | 124.64 Thousand | -555.41 Thousand | 2724.62 |
| Cash at beginning of period | 4.12 Million | 6.05 Million | 3.2 Million | 1.1 Million | 1.57 Million | 2.38 Million |
| Cash at end of period | 9.31 Million | 4.12 Million | 6.05 Million | 3.2 Million | 1.1 Million | 1.57 Million |
| Capital Expenditure | -458.35 Thousand | -351.73 Thousand | -5984.09 | -13.9 Thousand | -179.66 Thousand | -523.19 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 5.19 Million | -1.93 Million | 2.85 Million | 2.1 Million | -469.75 Thousand | -814.11 Thousand |
| Free Cash Flow | -15.23 Million | -8.25 Million | -4.04 Million | -1.52 Million | -1.84 Million | -2.3 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -4.22 Million | -4.2 Million | -13.68 Million | -3.76 Million | -3.52 Million | -3.76 Million |
| Depreciation & Amortization | 107.85 Thousand | 109.12 Thousand | 434.79 Thousand | 120.31 Thousand | 108.68 Thousand | 104.63 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -384.65 Thousand | 1.92 Million | -1.52 Million | -1.37 Million | 1.33 Million | -574.47 Thousand |
| Other non-cash items | 32.68 Thousand | -1.7 Million | 1.92 Million | 1.6 Million | -1.14 Million | 421.37 Thousand |
| Investing Cash Flow | 126.01 Thousand | - | -458.35 Thousand | -3591.87 | -95.47 Thousand | -107.11 Thousand |
| Investments in PPE | -3.35 | - | -458.35 Thousand | -3591.87 | -95.47 Thousand | -107.11 Thousand |
| Acquisitions | 126.01 Thousand | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 126.02 | - | - | - | - | - |
| Financing Cash Flow | 17.41 Million | -138.95 Thousand | 20.42 Million | -151.56 Thousand | -26.79 Thousand | 18.97 Million |
| Debt repayment | -273.09 Thousand | - | - | -69.00 | -138.00 | -69.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 17.58 Million | - | 20.66 Million | - | - | 19 Million |
| Other Financing Activities | 138.95 Thousand | - | -122.24 Thousand | -122.24 Thousand | - | - |
| Accounts receivables | -2.07 Million | 1.08 Million | -1.5 Million | -1.09 Million | 216.92 Thousand | -323.56 Thousand |
| Accounts payables | 1.67 Million | 865.42 Thousand | 464.42 Thousand | -258.46 Thousand | 1.14 Million | 111.45 Thousand |
| Inventory | 10.12 Thousand | -22.62 Thousand | -8617.89 | -8617.89 | - | - |
| Other working capital | 7424.41 | -2100.15 | -474.63 Thousand | -14.58 Thousand | -26.86 Thousand | -362.37 Thousand |
| Cash at beginning of period | 6.99 Million | 9.31 Million | 4.12 Million | 14.48 Million | 16.68 Million | 2.05 Million |
| Cash at end of period | 20.03 Million | 6.99 Million | 9.31 Million | 9.31 Million | 14.48 Million | 16.68 Million |
| Capital Expenditure | -3.35 | - | -458.35 Thousand | -3591.87 | -95.47 Thousand | -107.11 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 13.03 Million | -2.31 Million | 5.19 Million | -5.17 Million | -2.19 Million | 14.62 Million |
| Free Cash Flow | -4.5 Million | -2.17 Million | -15.23 Million | -5.02 Million | -2.17 Million | -4.34 Million |
NINTF
SGR-UN
CCOI
1257
IGC
8101